As life sciences enterprises navigate the clinical development’s growing complexity due to advanced therapies, increased data volumes, and the need for operational agility, outsourcing models are evolving in response. Sponsors now seek flexible, cost-efficient, and expertise-driven models to accelerate time-to-market and maintain regulatory compliance. This Viewpoint examines core characteristics, market shifts, and strategic implications of Full-service Outsourcing (FSO) and Functional Service Provider (FSP) models in clinical operations. Sponsors can benefit from tailored insights to assess and refine their clinical outsourcing strategy. The report explores the increasing adoption of hybrid models, the rising influence of AI and cloud-based infrastructures, and key decision-making factors, such as therapeutic complexity and trial geography. It highlights how enterprises can unlock greater control, scalability, and innovation in clinical trials by selecting the right outsourcing mix. It empowers decision-makers with strategic insights to navigate evolving outsourcing models, enabling them to enhance operational agility, optimize costs, and maintain greater oversight. Scope Industry: life sciences Geography: global Contents In this report, we examine FSO and FSP outsourcing models’ features and use cases Market trends influencing the shift in outsourcing approaches Key decision-making factors for selecting the right model Challenges in implementing and optimizing outsourcing strategies The growing relevance and advantages of hybrid models in clinical operations

Patient recruitment is a complex and dynamic part of clinical trial management, requiring proactive strategies, collaborations, and innovation to overcome challenges and achieve enrollment targets. Patient recruitment is vital for clinical trials, yet it presents challenges that impact study timelines, costs, and overall success. By adopting patient-centric approaches, using technology, and fostering collaborations across stakeholders, organizations can enhance recruitment efficiencies and accelerate study timelines, ultimately introducing new treatments to market faster for patients’ benefit worldwide. Patient recruitment in clinical trials will evolve due to technology advances, changing regulatory landscapes, and dynamic patient expectations. Outsourcing patient recruitment to specialized firms offers enterprises and Contract Research Organizations (CROs) opportunities to use expertise, scalability, and flexibility in navigating enrollment complexities. In this report, we examine the patient recruitment landscape, including the challenges that sponsors face. The report also assesses the current state of the supplier ecosystem and explores technology’s role in solving major challenges in patient recruitment. Scope Industry: life sciences Geography: global Services: life sciences BPS, life sciences ITS, and clinical development technology Contents In this report, we: Examine the patient recruitment landscape, including the challenges that sponsors face The report also assesses the current state of the supplier ecosystem and explores technology’s role in solving major challenges in patient recruitment Membership(s) Life Sciences Business Process Sourcing and Vendor Management